Posts by: Alice Melao

News

Psychological distress, even at low or moderate levels, increases the risk of arthritis, cardiovascular disease, and chronic obstructive pulmonary disease (COPD), researchers have found. This finding was reported in ... Read more

June 29, 2018June 29, 2018

New UK Study Recruiting Participants for Evaluation of Early COPD Risk Factors

News

A new clinical trial being conducted in the United Kingdom is recruiting participants to study the early stages of chronic obstructive pulmonary disease (COPD), and identify people at risk ... Read more

June 26, 2018June 26, 2018

Synairgen’s Antiviral Therapy SNG001 Proven Safe for COPD Patients in Phase 2 Trial

News

Preliminary results from a Phase 2 trial show that Synairgen’s investigative therapy SNG001 is well-tolerated by patients with chronic obstructive pulmonary disease (COPD). The ongoing two-part Phase 2 trial, called ... Read more

June 5, 2018June 5, 2018

Add-on Treatment with Fasenra Fails to Reduce COPD Worsening in TERRANOVA Trial

News

The investigational monoclonal antibody Fasenra (benralizumab) failed to reduce exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), top-line results of the Phase 3 TERRANOVA trial ... Read more

April 6, 2018April 6, 2018

Arch Biopartners’ Therapy Candidate AB569 Receives US Patent for Treatment of Chronic Lung Infections

News

AB569, Arch Biopartners’ lead therapy candidate, has received a U.S. patent for the treatment of chronic lung infections in patients with chronic obstructive pulmonary disease (COPD) or cystic fibrosis. Patent ... Read more

April 3, 2018April 3, 2018

Verona’s RPL554 Seems to Improve COPD Lung Function, Trial Results Show

News

Treatment with Verona Pharma’s investigative drug RPL554 can effectively improve lung function in patients with chronic obstructive pulmonary disease (COPD), results from a Phase 2b trial showed. The trial ... Read more

March 23, 2018March 23, 2018

PDGFD Gene Mutation Linked to Increased Risk of Corticosteroid-Induced Adrenal Suppression

News

A mutation of the PDGFD gene is linked to an increased risk of adrenal gland suppression, a serious side effect of inhaled corticosteroids used to treat asthma and chronic obstructive ... Read more

March 6, 2018March 6, 2018

New Stem Cells Seen to Restore Lung Air Sacs After Injury, May Help in COPD Research

News

A new subset of stem cells was found to expand quickly after lung injury and to specifically restore the tissues of air sacs, called alveoli, according to a study ... Read more

January 25, 2018January 25, 2018

Canadian INSPIRED Program Improves COPD Home-based Care, Reduces Hospital Use

News

Better and more adequate home-based care for patients with chronic obstructive pulmonary disease (COPD) can significantly improve their quality of life and reduce the need of hospital-based treatments. This ... Read more

December 7, 2017December 7, 2017

Phase 4 Trial Finds Tudorza Safe and Effective for COPD Patients with Cardiovascular Disease

News

Long-term use of Tudorza (aclidinium bromide) can significantly and safely reduce exacerbations in people with moderate to severe chronic obstructive pulmonary disease and cardiovascular disease or risk factors, findings ... Read more

Posts by: Alice Melao

Alice Melao

Low, Moderate Psychological Distress Increases Risk of COPD, Other Diseases, Study Shows

New UK Study Recruiting Participants for Evaluation of Early COPD Risk Factors

Synairgen’s Antiviral Therapy SNG001 Proven Safe for COPD Patients in Phase 2 Trial

Add-on Treatment with Fasenra Fails to Reduce COPD Worsening in TERRANOVA Trial

Arch Biopartners’ Therapy Candidate AB569 Receives US Patent for Treatment of Chronic Lung Infections

Verona’s RPL554 Seems to Improve COPD Lung Function, Trial Results Show

PDGFD Gene Mutation Linked to Increased Risk of Corticosteroid-Induced Adrenal Suppression

New Stem Cells Seen to Restore Lung Air Sacs After Injury, May Help in COPD Research

Canadian INSPIRED Program Improves COPD Home-based Care, Reduces Hospital Use

Phase 4 Trial Finds Tudorza Safe and Effective for COPD Patients with Cardiovascular Disease

Pin It on Pinterest